PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
TRxADE HEALTH, Inc. (MEDS)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINUS89846A2078
CUSIP89846A207
SectorHealthcare
IndustryPharmaceutical Retailers

Highlights

Market Cap$7.75M
EPS-$5.46
Revenue (TTM)$9.37M
Gross Profit (TTM)$4.58M
EBITDA (TTM)-$2.54M
Year Range$1.79 - $21.59
Target Price$6.75
Short %3.86%
Short Ratio0.06

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


TRxADE HEALTH, Inc.

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in TRxADE HEALTH, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%20.00%NovemberDecember2024FebruaryMarchApril
-99.99%
23.87%
MEDS (TRxADE HEALTH, Inc.)
Benchmark (^GSPC)

S&P 500

Returns By Period

TRxADE HEALTH, Inc. had a return of 150.70% year-to-date (YTD) and 163.16% in the last 12 months. Over the past 10 years, TRxADE HEALTH, Inc. had an annualized return of -5.33%, while the S&P 500 had an annualized return of 10.52%, indicating that TRxADE HEALTH, Inc. did not perform as well as the benchmark.


PeriodReturnBenchmark
Year-To-Date150.70%6.92%
1 month-33.93%-2.83%
6 months111.46%23.86%
1 year163.16%23.33%
5 years (annualized)14.58%11.66%
10 years (annualized)-5.33%10.52%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2024-19.75%128.30%122.05%
2023-7.98%-17.21%0.51%-11.18%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current risk-adjusted rank of MEDS is 84, placing it in the top 16% of the market in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.

The Risk-Adjusted Performance Rank of MEDS is 8484
TRxADE HEALTH, Inc.(MEDS)
The Sharpe Ratio Rank of MEDS is 7272Sharpe Ratio Rank
The Sortino Ratio Rank of MEDS is 9393Sortino Ratio Rank
The Omega Ratio Rank of MEDS is 9292Omega Ratio Rank
The Calmar Ratio Rank of MEDS is 9090Calmar Ratio Rank
The Martin Ratio Rank of MEDS is 7575Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for TRxADE HEALTH, Inc. (MEDS) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


MEDS
Sharpe ratio
The chart of Sharpe ratio for MEDS, currently valued at 0.73, compared to the broader market-2.00-1.000.001.002.003.004.000.73
Sortino ratio
The chart of Sortino ratio for MEDS, currently valued at 3.33, compared to the broader market-4.00-2.000.002.004.006.003.33
Omega ratio
The chart of Omega ratio for MEDS, currently valued at 1.43, compared to the broader market0.501.001.501.43
Calmar ratio
The chart of Calmar ratio for MEDS, currently valued at 1.71, compared to the broader market0.002.004.006.001.71
Martin ratio
The chart of Martin ratio for MEDS, currently valued at 3.24, compared to the broader market0.0010.0020.0030.003.24
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 2.19, compared to the broader market-2.00-1.000.001.002.003.004.002.19
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 3.18, compared to the broader market-4.00-2.000.002.004.006.003.18
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.38, compared to the broader market0.501.001.501.38
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.68, compared to the broader market0.002.004.006.001.68
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 8.62, compared to the broader market0.0010.0020.0030.008.62

Sharpe Ratio

The current TRxADE HEALTH, Inc. Sharpe ratio is 0.73. A Sharpe ratio between 0 and 1.0 is considered sub-optimal.


Rolling 12-month Sharpe Ratio-0.500.000.501.001.502.002.503.00NovemberDecember2024FebruaryMarchApril
0.73
2.19
MEDS (TRxADE HEALTH, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History

TRxADE HEALTH, Inc. granted a 253.57% dividend yield in the last twelve months. The annual payout for that period amounted to $16.00 per share.


PeriodTTM
Dividend$16.00

Dividend yield

253.57%

Monthly Dividends

The table displays the monthly dividend distributions for TRxADE HEALTH, Inc.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDec
2024$16.00

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%NovemberDecember2024FebruaryMarchApril
-99.99%
-2.94%
MEDS (TRxADE HEALTH, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the TRxADE HEALTH, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the TRxADE HEALTH, Inc. was 100.00%, occurring on Oct 26, 2017. The portfolio has not yet recovered.

The current TRxADE HEALTH, Inc. drawdown is 99.99%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-100%Jul 30, 20091758Oct 26, 2017
-38.89%Jun 29, 20092Jun 30, 20095Jul 24, 20097
-5.12%Apr 28, 20091Apr 28, 20098Jun 9, 20099
-1.18%Jun 12, 20091Jun 12, 20091Jun 25, 20092
-0.67%Feb 26, 20091Feb 26, 20092Mar 17, 20093

Volatility

Volatility Chart

The current TRxADE HEALTH, Inc. volatility is 19.11%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%20.00%40.00%60.00%80.00%100.00%120.00%NovemberDecember2024FebruaryMarchApril
19.11%
3.65%
MEDS (TRxADE HEALTH, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of TRxADE HEALTH, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

0.00

Cost Of Revenue

0.00

Gross Profit

0.00
Operating Expenses

Selling, General & Admin Expenses

0.00

R&D Expenses

0.00

Total Operating Expenses

0.00
Income

Income Before Tax

0.00

Operating Income

0.00

EBIT

0.00

Earnings From Continuing Operations

0.00

Net Income

0.00

Income Tax Expense

0.00

Interest Expense

0.00

Other Non-Operating Income (Expenses)

0.00

Extraordinary Items

0.00

Discontinued Operations

0.00

Effect Of Accounting Charges

0.00

Non Recurring

0.00

Minority Interest

0.00

Other Items

0.00
Values in undefined except per share items